Kineta Stock (NASDAQ:KA)
Previous Close
$0.83
52W Range
$0.33 - $5.39
50D Avg
$0.65
200D Avg
$1.12
Market Cap
$7.05M
Avg Vol (3M)
$504.10K
Beta
0.57
Div Yield
-
KA Company Profile
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.